Cost-effectiveness Analysis of Three Sulfonylureas in Treatment of Noninsulin Dependent Diabetes Mellitus / 中国药房
China Pharmacy
; (12)2001.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-523656
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE:
To compare the therapeutic effects and costs among glimepiride,glipizide and gliclazide on patients with noninsulin dependent diabetes mellitusMETHODS:
85 patients were randomized into three groupsgroup A received glimepiride,group B received glipizide and group C received gliclazide Pharmacoeconomic evaluation was performed by minimized costanalysis:
RESULTS:
The effective rates of group A,group B and group C were 85 71%,86 21% and 85 71%,respectively The adverse reaction rates were 7 14%,6 90% and 10 71%,and the expenditures 682 64 yuans,436 24 yuans and 464 34 yuans,respectivelyCONCLUSION:
By cost-effectiveness analysis,glipizide is best one among three sulfonylureas
Texto completo:
Disponível
Contexto em Saúde:
Agenda de Saúde Sustentável para as Américas
Problema de saúde:
Objetivo 4: Financiamento para a saúde
Base de dados:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Ensaio clínico controlado
/
Avaliação econômica em saúde
Idioma:
Chinês
Revista:
China Pharmacy
Ano de publicação:
2001
Tipo de documento:
Artigo